12-66517991-G-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001366722.1(GRIP1):​c.503-15C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.259 in 1,454,456 control chromosomes in the GnomAD database, including 50,228 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.27 ( 5667 hom., cov: 32)
Exomes 𝑓: 0.26 ( 44561 hom. )

Consequence

GRIP1
NM_001366722.1 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.118

Publications

10 publications found
Variant links:
Genes affected
GRIP1 (HGNC:18708): (glutamate receptor interacting protein 1) This gene encodes a member of the glutamate receptor interacting protein family. The encoded scaffold protein binds to and mediates the trafficking and membrane organization of a number of transmembrane proteins. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, May 2010]
GRIP1 Gene-Disease associations (from GenCC):
  • Fraser syndrome 3
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae)
  • Fraser syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 12-66517991-G-T is Benign according to our data. Variant chr12-66517991-G-T is described in ClinVar as [Benign]. Clinvar id is 261412.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.306 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GRIP1NM_001366722.1 linkc.503-15C>A intron_variant Intron 5 of 24 ENST00000359742.9 NP_001353651.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GRIP1ENST00000359742.9 linkc.503-15C>A intron_variant Intron 5 of 24 5 NM_001366722.1 ENSP00000352780.4 Q9Y3R0-1

Frequencies

GnomAD3 genomes
AF:
0.269
AC:
40835
AN:
151744
Hom.:
5662
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.311
Gnomad AMI
AF:
0.316
Gnomad AMR
AF:
0.225
Gnomad ASJ
AF:
0.292
Gnomad EAS
AF:
0.149
Gnomad SAS
AF:
0.248
Gnomad FIN
AF:
0.203
Gnomad MID
AF:
0.350
Gnomad NFE
AF:
0.272
Gnomad OTH
AF:
0.284
GnomAD2 exomes
AF:
0.240
AC:
59827
AN:
248892
AF XY:
0.247
show subpopulations
Gnomad AFR exome
AF:
0.314
Gnomad AMR exome
AF:
0.138
Gnomad ASJ exome
AF:
0.296
Gnomad EAS exome
AF:
0.157
Gnomad FIN exome
AF:
0.199
Gnomad NFE exome
AF:
0.270
Gnomad OTH exome
AF:
0.273
GnomAD4 exome
AF:
0.258
AC:
335570
AN:
1302594
Hom.:
44561
Cov.:
21
AF XY:
0.259
AC XY:
170298
AN XY:
656872
show subpopulations
African (AFR)
AF:
0.309
AC:
9407
AN:
30452
American (AMR)
AF:
0.147
AC:
6538
AN:
44500
Ashkenazi Jewish (ASJ)
AF:
0.294
AC:
7395
AN:
25134
East Asian (EAS)
AF:
0.130
AC:
5070
AN:
38952
South Asian (SAS)
AF:
0.264
AC:
21972
AN:
83072
European-Finnish (FIN)
AF:
0.202
AC:
10729
AN:
53080
Middle Eastern (MID)
AF:
0.285
AC:
1558
AN:
5468
European-Non Finnish (NFE)
AF:
0.267
AC:
258239
AN:
966892
Other (OTH)
AF:
0.266
AC:
14662
AN:
55044
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
11113
22227
33340
44454
55567
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8090
16180
24270
32360
40450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.269
AC:
40866
AN:
151862
Hom.:
5667
Cov.:
32
AF XY:
0.266
AC XY:
19753
AN XY:
74212
show subpopulations
African (AFR)
AF:
0.311
AC:
12871
AN:
41398
American (AMR)
AF:
0.225
AC:
3427
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
0.292
AC:
1010
AN:
3464
East Asian (EAS)
AF:
0.149
AC:
769
AN:
5160
South Asian (SAS)
AF:
0.249
AC:
1193
AN:
4800
European-Finnish (FIN)
AF:
0.203
AC:
2144
AN:
10556
Middle Eastern (MID)
AF:
0.332
AC:
97
AN:
292
European-Non Finnish (NFE)
AF:
0.272
AC:
18456
AN:
67918
Other (OTH)
AF:
0.290
AC:
611
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1499
2997
4496
5994
7493
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
432
864
1296
1728
2160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.271
Hom.:
18104
Bravo
AF:
0.269
Asia WGS
AF:
0.229
AC:
799
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Aug 15, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Fraser syndrome 1 Benign:2
Oct 09, 2014
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Fraser syndrome 3 Benign:2
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
7.9
DANN
Benign
0.49
PhyloP100
0.12
PromoterAI
-0.022
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11838180; hg19: chr12-66911771; COSMIC: COSV107266863; COSMIC: COSV107266863; API